Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia

BACKGROUND: Current chronic lymphocytic leukemia (CLL) International Prognostic Index (IPI) stratifies patients based on clinical, molecular, and biochemical features; however, B‐cell markers also influence CLL outcomes. Here, prognostic roles of CD11c, CD38, and CD49d were first evaluated, and then...

Descripción completa

Detalles Bibliográficos
Autores principales: Giudice, Valentina, Serio, Bianca, Bertolini, Angela, Mettivier, Laura, D'Alto, Francesca, Pezzullo, Luca, D'Addona, Matteo, Fumo, Rosalba, Zeppa, Pio, Gorrese, Marisa, Selleri, Carmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804478/
https://www.ncbi.nlm.nih.gov/pubmed/35871396
http://dx.doi.org/10.1111/ejh.13833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804478/
https://www.ncbi.nlm.nih.gov/pubmed/35871396
http://dx.doi.org/10.1111/ejh.13833

Ejemplares similares